// App-Quantinova.ai

2821 : Characterization of CDK inhibitors in a biochemical assay using a comprehensive panel of human CDK-cyclin complexes

Researchers

Presenter

  • Daniel Mueller

Principal Investigators

  • Frank Totzke

  • Thomas Weber

  • Christian Beisenherz-Huss

  • Diane Kraemer

  • Carolin Heidemann-Dinger

  • Constance Ketterer

  • Chris Eckert

  • Michael H.G. Kubbutat

Medical Centers

  • ProQinase GmbH, Freiburg, Germany

Locations

  • Germany

Companies

  • ProQinase GmbH

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved